Elizabeth A. Tovar

Metabolic profiling of triple-negative breast cancer cells reveals metabolic vulnerabilities

Nathan Lanning, Joshua Castle, Simar Singh et al. · Cancer & Metabolism · 2017 · 166 citations · Full text

Glesatinib Exhibits Antitumor Activity in Lung Cancer Models and Patients Harboring <i>MET</i> Exon 14 Mutations and Overcomes Mutation-mediated Resistance to Type I MET Inhibitors in Nonclinical Models

Lars D. Engstrom, Ruth Aranda, Matthew Lee et al. · Clinical Cancer Research · 2017 · 145 citations · Full text

Targeting MET and EGFR crosstalk signaling in triple-negative breast cancers

Erik S. Linklater, Elizabeth A. Tovar, Curt J. Essenburg et al. · Oncotarget · 2016 · 77 citations · Full text

Breast Oncology, Kinase Inhibitors, Cancer Biology +16

NF1 deficiency correlates with estrogen receptor signaling and diminished survival in breast cancer

Patrick S. Dischinger, Elizabeth A. Tovar, Curt J. Essenburg et al. · npj Breast Cancer · 2018 · 61 citations · Full text

Cabozantinib (XL184) Inhibits Growth and Invasion of Preclinical TNBC Models

Mansoureh Sameni, Elizabeth A. Tovar, Curt J. Essenburg et al. · Clinical Cancer Research · 2015 · 52 citations · Full text